These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29963273)

  • 1. Subcellular localization of MCM2 correlates with the prognosis of ovarian clear cell carcinoma.
    Aihemaiti G; Kurata M; Nogawa D; Yamamoto A; Mineo T; Onishi I; Kinowaki Y; Jin XH; Tatsuzawa A; Miyasaka N; Kitagawa M; Yamamoto K
    Oncotarget; 2018 Jun; 9(46):28213-28225. PubMed ID: 29963273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors.
    Abe S; Yamamoto K; Kurata M; Abe-Suzuki S; Horii R; Akiyama F; Kitagawa M
    Oncotarget; 2015 Oct; 6(33):34892-909. PubMed ID: 26430873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minichromosome maintenance 2 bound with retroviral Gp70 is localized to cytoplasm and enhances DNA-damage-induced apoptosis.
    Abe S; Kurata M; Suzuki S; Yamamoto K; Aisaki K; Kanno J; Kitagawa M
    PLoS One; 2012; 7(6):e40129. PubMed ID: 22768239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel role for acinus and MCM2 as host-specific signaling enhancers of DNA-damage-induced apoptosis in association with viral protein gp70.
    Hasegawa M; Kurata M; Yamamoto K; Yoshida K; Aizawa S; Kitagawa M
    Leuk Res; 2009 Aug; 33(8):1100-7. PubMed ID: 19058849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA damage-induced apoptosis and genetic background of the host: host-specific signaling enhancers of apoptosis.
    Kurata M; Abe S; Suzuki S; Li N; Ohnishi I; Hasegawa M; Yamamoto K; Kitagawa M
    J Med Dent Sci; 2011 Jul; 58(2):85-8. PubMed ID: 23896790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minichromosome maintenance protein 2 expression in normal kidney and renal cell carcinomas: relationship to tumor dormancy and potential clinical utility.
    Rodins K; Cheale M; Coleman N; Fox SB
    Clin Cancer Res; 2002 Apr; 8(4):1075-81. PubMed ID: 11948116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.
    Ramnath N; Hernandez FJ; Tan DF; Huberman JA; Natarajan N; Beck AF; Hyland A; Todorov IT; Brooks JS; Bepler G
    J Clin Oncol; 2001 Nov; 19(22):4259-66. PubMed ID: 11709570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of minichromosome maintenance protein 2 as a marker for proliferation and prognosis in diffuse large B-cell lymphoma: a tissue microarray and clinico-pathological analysis.
    Obermann EC; Went P; Zimpfer A; Tzankov A; Wild PJ; Stoehr R; Pileri SA; Dirnhofer S
    BMC Cancer; 2005 Dec; 5():162. PubMed ID: 16368013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MCM2 and TIP30 are prognostic markers in squamous cell/adenosquamous carcinoma and adenocarcinoma of the gallbladder.
    Liu Z; Yang Z; Jiang S; Zou Q; Yuan Y; Li J; Li D; Liang L; Chen M; Chen S
    Mol Med Rep; 2016 Nov; 14(5):4581-4592. PubMed ID: 27748889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of minichromosome maintenance-2 in human malignant fibrous histiocytomas: Correlations with Ki-67 and P53 expression, and apoptosis.
    Osaki M; Osaki M; Yamashita H; Shomori K; Yoshida H; Ito H
    Int J Mol Med; 2002 Aug; 10(2):161-8. PubMed ID: 12119552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA-dependent protein kinase enhances DNA damage-induced apoptosis in association with Friend gp70.
    Yamaguchi S; Hasegawa M; Aizawa S; Tanaka K; Yoshida K; Noda Y; Tatsumi K; Hirokawa K; Kitagawa M
    Leuk Res; 2005 Mar; 29(3):307-16. PubMed ID: 15661267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of minichromosome maintenance 2 (MCM2), Ki-67, and cell-cycle-related molecules, and apoptosis in the normal-dysplasia-carcinoma sequence of the oral mucosa.
    Kodani I; Shomori K; Osaki M; Kuratate I; Ryoke K; Ito H
    Pathobiology; 2001; 69(3):150-8. PubMed ID: 11872961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer.
    Yang J; Ramnath N; Moysich KB; Asch HL; Swede H; Alrawi SJ; Huberman J; Geradts J; Brooks JS; Tan D
    BMC Cancer; 2006 Aug; 6():203. PubMed ID: 16882345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.
    Liu DC; Yang ZL
    Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.
    May M; Burger M; Otto W; Hakenberg OW; Wieland WF; May D; Hofstädter F; Götz S; Niessl N; Fritsche HM; Birnkammer K; Gilfrich C; Peter J; Jain A; Koch S; Lebentrau S; Riedmiller H; Rössler W; Denzinger S; Brookman-May S; Gunia S
    BJU Int; 2013 Aug; 112(4):E383-90. PubMed ID: 23305250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mcm2, Geminin, and KI67 define proliferative state and are prognostic markers in renal cell carcinoma.
    Dudderidge TJ; Stoeber K; Loddo M; Atkinson G; Fanshawe T; Griffiths DF; Williams GH
    Clin Cancer Res; 2005 Apr; 11(7):2510-7. PubMed ID: 15814627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minichromosome maintenance protein 2 is a reliable proliferative marker in breast carcinoma.
    Reena RM; Mastura M; Siti-Aishah MA; Munirah MA; Norlia A; Naqiyah I; Rohaizak M; Sharifah NA
    Ann Diagn Pathol; 2008 Oct; 12(5):340-3. PubMed ID: 18774496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minichromosome maintenance 2 (MCM2) is a new prognostic proliferative marker in Wilms tumour.
    Taran K; Sitkiewicz A; Andrzejewska E; Kobos J
    Pol J Pathol; 2011; 62(2):84-8. PubMed ID: 21866463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the nuclear export protein chromosomal region maintenance/exportin 1/Xpo1 is a prognostic factor in human ovarian cancer.
    Noske A; Weichert W; Niesporek S; Röske A; Buckendahl AC; Koch I; Sehouli J; Dietel M; Denkert C
    Cancer; 2008 Apr; 112(8):1733-43. PubMed ID: 18306389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.